Development of a Novel DPI: Opportunities and Constraints
A case study in the development of a novel dry powder inhaler (DPI)
that puts the patient at the centre of the design process.
By Guillaume Brouet and Christophe Fagot at Valois Pharma (December 2009)
Keywords: Novel DPI, dry poder Inhaler, therapy, Brouet, Fagot, Valois Pharma, In Vivo, In Vitro,